Deimination or citrullination, a post-translational modification with many physiological and pathophysiological facets;La désimination ou citrullination Une modification post-traductionnelle aux multiples facettes

Medecine/Sciences

Volumn 27, Issue 1, 2011, Pages 49-54

  Méchin, Marie Claire ^a   Nachat, Rachida ^a   Coudane, Fanny ^a   Adoue, Véronique ^a   Arnaud, Jacques ^a   Serre, Guy ^a   Simon, Michel ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALCIUM; CITRULLINE; HYDROLASE; ISOENZYME; MYELIN PROTEIN; PAD6 PROTEIN, MOUSE; PROTEIN ARGININE DEIMINASE; PROTEIN-ARGININE DEIMINASE;

ANIMAL; AUTOIMMUNE DISEASE; BODY WATER; CHROMATIN; CORNEA; ENZYMOLOGY; EPIDERMIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR EVOLUTION; MOUSE; NEOPLASM; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SKIN DISEASE;

ANIMALS; ARGININE; AUTOIMMUNE DISEASES; BODY WATER; CALCIUM; CHROMATIN; CITRULLINE; CONSERVED SEQUENCE; CORNEA; EPIDERMIS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; HUMANS; HYDROLASES; ISOENZYMES; MICE; MYELIN PROTEINS; NEOPLASMS; NERVOUS SYSTEM DISEASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SKIN DISEASES;

EID: 79951876761     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/201127149     Document Type: Review

References (33)

1. Chavanos S, Méchin MC, Takahora H, et al. Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene 2004 ; 330:19-27.
2. Wright PW, Bolling LC, Calvert ME, et al. ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev Biol 2003 ; 256:73-88. (Pubitemid 36332206)
3. Esposito G, Vitale AM, Leijten FP, et al. Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol Cell Endocrinol 2007 ; 273:25-31. (Pubitemid 47023023)
4. Nachat R, Méchin MC, Takahara H, et al. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J Invest Dermatol 2005 ; 124:384-93. (Pubitemid 40175886)
5. Kamata Y, Taniguchi A, Yamamoto M, et al. Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids. J Biol Chem 2009 ; 284: 12829-36.
6. Méchin MC, Sebbag M, Arnaud J, et al. Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases. Int J Cosmet Sci 2007 ; 29:147-68. (Pubitemid 47024254)
7. Méchin MC, Enji M, Nachat R, et al. The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations. Cell Mol Life Sci 2005 ; 62: 1984-95. (Pubitemid 41261845)
8. ying S, Dong S, Kawada A, et al. Transcriptional regulation of peptidylarginine deiminase expression in human keratinocytes. J Dermatol Sci 2009 ; 53:2-9.
9. Adoue V, Chávanos S, Coudane F, et al. Long-range enhancer differentially regulated by c-Jun and JunD controls peptidylarginine deiminase-3 gene in keratinocytes. J Mol Biol 2008 ; 384:1048-57.
10. Chavanos S, Adoue V, Méchin MC, et al. Long-range enhancer associated with chromatin looping allows AP-1 regulation of the peptidylarginine deiminase 3 gene in differentiated keratinocyte. PLoS One 2008; 3 :e3408.
11. Méchin MC, Coudane F, Adoue V, et al. Deimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminases. Cell Mol Life Sci 2010 ; 67: 1491-503.
12. Wood DD, Bilbao JM, O'Connors P, Moscarello MA. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 1996; 40: 18-24. (Pubitemid 26250138)
13. Moscarello MA, Mastronardi FG, Wood DD. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurocbem Res 2007; 32: 251-6. (Pubitemid 46238870)
14. Musse AA, Li Z, Ackerley CA, et al. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech 2008 ; 1: 229-40.
15. Ishigami A, Ohsawa T, Hiratsuka M, et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosa Res 2005 ; 80: 120-8. (Pubitemid 40577300)
16. Jang B, Kim E, Choi JK, et al. Accumulation of citrullinated proteins by upregulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol 2008 ; 173: 1129-42.
17. Jang B, Jin JK, Jeon YC, et al. Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 2010 ; 119: 199-210.
18. FengD, Imasawa T, NaganoT, et al. Citrullination preferentially proceeds in glomerular Bowman's capsule and increases in obstructive nephropathy. Kidney Int 2005;68:84-95.
19. Vincent C, Nogueira L, Clavel C, et al. Autoantibodies to citrullinated proteins: ACPA. autoimmunity 2005 ; 38:17-24.
20. Sebbag M, Clavel C, Nogueira L, et al. Autoimmune response to posttranslationally modified (citrullinated) proteins: prime suspect in the pathophysiology of rheumatoid arthritis. In : Zouali M, ed. The epigenetics of autoimmune diseases. New York : Wiley, 2009:279-308.
21. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001 ; 166:4177-84. (Pubitemid 32224951)
22. Suzuki A, ydmada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003 ; 34: 395-402. (Pubitemid 36935332)
23. Gandjbakhch F, Fajardy I, Ferre B, et al. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.J Rheumatol 2009; 36:881-6.
24. Burr ML, Naseem H, Hinks A, et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian Papulation. Ann Rheum Dis 2010 ; 69:666-70.
25. Foulquier C, Sebbag M, Clavel C, et al. Peptidyl arginine deiminase type 2 (PAD2) and PAO-4 but not PAD-I, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007; 56: 3541-53. (Pubitemid 350100687)
26. Proost P, Loos T, Mortier A, et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.; J Exp Med 2008 ; 205: 2085-97.
27. Chang X, Han J, Pang L, et al. Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 2009 ; 9:40.
28. yao H, Li P, Venters BJ, et al. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem 2008 ; 283: 20060-8.
29. Cuthbert GL, Daujat S, Snowden AW, et al. Histone deimination antagonizes arginine methylation. Cell 2004 ; 118: 645-53.
30. Wang Y, Wysocka J, SayeghJ, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004 ; 306: 279-83. (Pubitemid 39336873)
31. Ray-Gallet D, Gerard A, Polo S, Almouzni G. Variations sur le thème du « code histone ». Med Sci (Paris) 2005 ; 21: 384-9.
32. Wang Y, Li M, Stadler S, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009 ; 184:205-13.
33. Gougerot-Pocidalo MA, El Benna J, My-Chan Dang P, Elbim C. Quand les polynucléaires neutrophils attrapent les agents pathogènes dans leurs filets. Med Sci (Paris) 2007; 23:464-5. (Pubitemid 46826167)